[Form 4] Synopsys Inc Insider Trading Activity
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
MAHONEY RICHARD S.
Role
Chief Revenue Officer
Sold
9,010 shs ($4.25M)
Approx. gross sale proceeds
$4.25M
Approx. exercise cost
$1.36M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 2,949 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 1,192 | $0.00 | $0.00 |
| Sale | Common Stock | 4,869 | $471.1892 | $2.29M |
| Exercise | Common Stock | 2,949 | $319.20 | $941K |
| Sale | Common Stock | 2,949 | $471.2728 | $1.39M |
| Exercise | Common Stock | 1,192 | $354.45 | $423K |
| Sale | Common Stock | 1,192 | $471.1758 | $562K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 10,071 contracts (Direct);
Common Stock — 1,485 shares (Direct)
Footnotes (4)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 13, 2024.
- F2. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $469.07 to $473.33. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F3. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $469.14 to $473.33. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F4. 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.